- Home
- HNGE
HNGE
HINGE HEALTH INC
as 06-17-2025 4:00pm EST
Stocks
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients. The Company's clients are self-insured employers.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 3.1B | IPO Year: | 2025 |
| Target Price: | $45.64 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 4.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $33.42 - $43.80 | Next Earning Date: | 01-01-0001 |
| Revenue: | $431,521,000 | Revenue Growth: | 33.37% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest HINGE HEALTH INC News
HNGE Breaking Stock News: Dive into HNGE Ticker-Specific Updates for Smart Investing
TipRanks
a day ago
Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
TipRanks
a day ago
Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus
Business Wire
a day ago
Hinge Health Announces HingeSelect - a High-performance Network Delivering Unified Musculoskeletal Care
The Wall Street Journal
a day ago
Health Care Roundup: Market Talk
Yahoo Finance Video
2 days ago
Hinge Health: Why this analyst is bullish on the stock
Investing.com
2 days ago
Analysts start with bullish ratings on Hinge Health on growth potential
Yahoo Finance Video
2 days ago
Tesla price hikes, Roku–Amazon, Hinge Health analyst coverage
Investopedia
2 days ago
Hinge Health Stock Rises After Analysts Back the May IPO's Shares
Compare HNGE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HNGE HINGE HEALTH INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.